Rekvina Labs

{
  "main_header": {
    "sid": 576337,
    "name": "Rekvina Labs",
    "stock_name": "Rekvina Labs",
    "full_name": "Rekvina Labs Ltd",
    "name_url": "stocks-analysis/rekvina-labs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "40.61",
    "chg": -0.82,
    "chgp": "-1.98%",
    "dir": -1,
    "prev_price": "41.43",
    "mcapval": "25.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 526075,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "sector_id": "",
    "indexname": "India SENSEX",
    "isin": "INE092O01028",
    "curr_date": "Jun 09, 03:30 PM",
    "curr_time": "06:33 AM",
    "last_traded_at": "Jun 09, 03:30 PM IST",
    "bse_nse_vol": "12 ",
    "exc_status": "Active",
    "traded_date": "Jun 09, 2026",
    "traded_date_str": "2026 06 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/rekvina-labs-576337-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Rekvina Labs Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-rekvina-labs-ltd-latest-results-good-or-bad-4006942",
        "imagepath": "",
        "date": "2026-05-22 19:21:20",
        "description": "Rekvina Labs Ltd's latest financial results for Q4 FY26 indicate a complex situation characterized by both operational challenges and some signs of sequential improvement. The company reported net sales of ₹0.72 crores, which reflects a significant sequential growth of 105.71% from ₹0.35 crores in the previous quarter. This marks a notable recovery in revenue generation, as the company had previously reported zero sales in earlier quarters.\n\nDespite the increase in revenue, Rekvina Labs continues to face persistent profitability issues, reporting a net loss of ₹0.06 crores, although this represents a 50% improvement from the loss of ₹0.12 crores in Q3 FY26. The operating margin also showed some improvement, moving from -34.29% in Q3 FY26 to -8.33% in the latest quarter. This suggests that while the company is managing to grow its revenue, it still struggles to achieve positive operating cash flow.\n\nThe mark..."
      },
      {
        "title": "Rekvina Labs Q4 FY26: Losses Deepen Despite Revenue Revival in Struggling Micro-Cap Pharma",
        "link": "https://www.marketsmojo.com/news/result-analysis/rekvina-labs-q4-fy26-losses-deepen-despite-revenue-revival-in-struggling-micro-cap-pharma-4005449",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/RekvinaLabs_quaterlyResult_4005449.png",
        "date": "2026-05-22 11:47:11",
        "description": "Rekvina Labs Limited, a micro-cap pharmaceutical contract manufacturer with a market capitalisation of ₹20.00 crores, reported a net loss of ₹0.06 crores for Q4 FY26 (Mar'26), marking a 50.00% reduction in losses compared to the previous quarter's ₹0.12 crores loss. Whilst the company demonstrated sequential revenue growth of 105.71% to reach ₹0.72 crores in Q4 FY26, the persistent inability to achieve profitability and negative operating margins continue to raise serious concerns about the viability of its business model."
      },
      {
        "title": "When is the next results date for Rekvina Labs Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-rekvina-labs-ltd-3999854",
        "imagepath": "",
        "date": "2026-05-19 23:19:40",
        "description": "The next results date for Rekvina Labs Ltd is scheduled for 21 May 2026...."
      },
      {
        "title": "Rekvina Labs Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/rekvina-labs-ltd-is-rated-sell-by-marketsmojo-3992618",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/RekvinaLabsLtd_mojoScore_3992618.png",
        "date": "2026-05-15 10:10:02",
        "description": "Rekvina Labs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 May 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Rekvina Labs Ltd to 52-Week High of Rs 46.65",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rekvina-labs-ltd-hits-new-52-week-high-at-rs4665-3964376",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/RekvinaLabsLtd_priceRelatedfactors_3964376.png",
        "date": "2026-04-27 10:35:19",
        "description": "With a sustained four-day rally culminating in a fresh 52-week high of Rs 46.65 on 27 Apr 2026, Rekvina Labs Ltd has demonstrated remarkable price momentum, trading well above all key moving averages and signalling robust technical health despite a modest underperformance relative to its sector today."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Rekvina Labs Ltd to 52-Week High of Rs 45.74",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rekvina-labs-ltd-hits-new-52-week-high-at-rs4574-3960781",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/RekvinaLabsLtd_priceRelatedfactors_3960781.png",
        "date": "2026-04-24 10:35:13",
        "description": "With a decisive break above Rs 45.74 on 24 Apr 2026, Rekvina Labs Ltd has reached a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum despite a broadly weakening market backdrop."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Rekvina Labs Ltd to 52-Week High of Rs 44.85",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rekvina-labs-ltd-hits-new-52-week-high-at-rs4485-3959134",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/RekvinaLabsLtd_priceRelatedfactors_3959134.png",
        "date": "2026-04-23 10:40:40",
        "description": "With every major technical indicator aligned to the upside, Rekvina Labs Ltd surged to a fresh 52-week high of Rs 44.85 on 23 Apr 2026, marking a significant milestone in its price momentum after a steady two-day gain of 4.01%."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Rekvina Labs Ltd to 52-Week High of Rs 43.99",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rekvina-labs-ltd-hits-new-52-week-high-at-rs4399-3953961",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/RekvinaLabsLtd_priceRelatedfactors_3953961.png",
        "date": "2026-04-20 10:35:17",
        "description": "With a sustained nine-day rally delivering a 19.38% gain, Rekvina Labs Ltd surged to a fresh 52-week high of Rs 43.99 on 20 Apr 2026, marking a significant milestone in its price momentum."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Rekvina Labs Ltd to 52-Week High of Rs 43.13",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rekvina-labs-ltd-hits-new-52-week-high-at-rs4313-3950868",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/RekvinaLabsLtd_priceRelatedfactors_3950868.png",
        "date": "2026-04-17 10:35:30",
        "description": "With a sustained rally over the past eight trading sessions, Rekvina Labs Ltd has surged 17.04% to touch a new 52-week high of Rs 43.13 on 17 Apr 2026, marking a significant milestone from its 52-week low of Rs 6.75. This price momentum is underpinned by a confluence of bullish technical indicators across multiple timeframes, signalling robust upward momentum."
      }
    ],
    "total": 65,
    "sid": "576337",
    "stock_news_url": "https://www.marketsmojo.com/news/rekvina-labs-576337"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 21St May 2026",
      "datetime": "21-May-2026",
      "details": "Pursuant to Reg 33 read with Part A of Schedule III of SEBI (LODR) Regulation 2015 we hereby submitting the following: 1. Standalone Audited Financial Results for the Quarter ended and Year ended on March 31 2026 along with Assets & Liability Statement & Cash Flow Statement with Independent Auditor Report 2. Declaration of Auditor Report with unmodified Opinion pursuant to Reg 33 (3)(d) of Listing Regulations signed by Mr. Amit Shah Director of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Financial Results For Quarter Ended & Year Ended On March 31 2026.",
      "datetime": "21-May-2026",
      "details": "Standalone Audited Financial Results for the Quarter ended & Year ended on March 31 2026 along with statement of Assets & Liabilities Cash Flow statement & unmodified Audit Report.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Consider And Approve Financial Result For The QTR 4",
      "datetime": "18-May-2026",
      "details": "Rekvina Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 inter alia to consider and approve Financial Result for the Quarter and Year ended 31.03.2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Rekvina Labs Ltd has announced <strong>5:10</strong> stock split, ex-date: 30 Apr 14",
          "dt": "2014-04-30",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Are Rekvina Labs Ltd latest results good or bad?

2026-05-22 19:21:20

Rekvina Labs Ltd's latest financial results for Q4 FY26 indicate a complex situation characterized by both operational challenges and some signs of sequential improvement. The company reported net sales of ₹0.72 crores, which reflects a significant sequential growth of 105.71% from ₹0.35 crores in the previous quarter. This marks a notable recovery in revenue generation, as the company had previously reported zero sales in earlier quarters. Despite the increase in revenue, Rekvina Labs continues to face persistent profitability issues, reporting a net loss of ₹0.06 crores, although this represents a 50% improvement from the loss of ₹0.12 crores in Q3 FY26. The operating margin also showed some improvement, moving from -34.29% in Q3 FY26 to -8.33% in the latest quarter. This suggests that while the company is managing to grow its revenue, it still struggles to achieve positive operating cash flow. The mark...

Read full news article

Rekvina Labs Q4 FY26: Losses Deepen Despite Revenue Revival in Struggling Micro-Cap Pharma

2026-05-22 11:47:11

Rekvina Labs Limited, a micro-cap pharmaceutical contract manufacturer with a market capitalisation of ₹20.00 crores, reported a net loss of ₹0.06 crores for Q4 FY26 (Mar'26), marking a 50.00% reduction in losses compared to the previous quarter's ₹0.12 crores loss. Whilst the company demonstrated sequential revenue growth of 105.71% to reach ₹0.72 crores in Q4 FY26, the persistent inability to achieve profitability and negative operating margins continue to raise serious concerns about the viability of its business model.

Read full news article

When is the next results date for Rekvina Labs Ltd?

2026-05-19 23:19:40

The next results date for Rekvina Labs Ltd is scheduled for 21 May 2026....

Read full news article

Rekvina Labs Ltd is Rated Sell by MarketsMOJO

2026-05-15 10:10:02

Rekvina Labs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 May 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Broad-Based Technical Strength Lifts Rekvina Labs Ltd to 52-Week High of Rs 46.65

2026-04-27 10:35:19

With a sustained four-day rally culminating in a fresh 52-week high of Rs 46.65 on 27 Apr 2026, Rekvina Labs Ltd has demonstrated remarkable price momentum, trading well above all key moving averages and signalling robust technical health despite a modest underperformance relative to its sector today.

Read full news article

Broad-Based Technical Strength Lifts Rekvina Labs Ltd to 52-Week High of Rs 45.74

2026-04-24 10:35:13

With a decisive break above Rs 45.74 on 24 Apr 2026, Rekvina Labs Ltd has reached a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum despite a broadly weakening market backdrop.

Read full news article

Broad-Based Technical Strength Lifts Rekvina Labs Ltd to 52-Week High of Rs 44.85

2026-04-23 10:40:40

With every major technical indicator aligned to the upside, Rekvina Labs Ltd surged to a fresh 52-week high of Rs 44.85 on 23 Apr 2026, marking a significant milestone in its price momentum after a steady two-day gain of 4.01%.

Read full news article

Broad-Based Technical Strength Lifts Rekvina Labs Ltd to 52-Week High of Rs 43.99

2026-04-20 10:35:17

With a sustained nine-day rally delivering a 19.38% gain, Rekvina Labs Ltd surged to a fresh 52-week high of Rs 43.99 on 20 Apr 2026, marking a significant milestone in its price momentum.

Read full news article

Broad-Based Technical Strength Lifts Rekvina Labs Ltd to 52-Week High of Rs 43.13

2026-04-17 10:35:30

With a sustained rally over the past eight trading sessions, Rekvina Labs Ltd has surged 17.04% to touch a new 52-week high of Rs 43.13 on 17 Apr 2026, marking a significant milestone from its 52-week low of Rs 6.75. This price momentum is underpinned by a confluence of bullish technical indicators across multiple timeframes, signalling robust upward momentum.

Read full news article

View All News